Cao, Chunxiang <br/><br/>
Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.  [electronic resource] 

 -  Japanese journal of clinical oncology  Dec 2015 
 - 1122-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-3621 
<br/><br/><label>Standard No.: </label>10.1093/jjco/hyv141  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Asian People<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Drug Combinations<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Liver Neoplasms--drug therapy<br/>Lung Neoplasms--drug therapy<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Oxonic Acid--administration & dosage<br/>Pancreatic Neoplasms--drug therapy<br/>Peritoneal Neoplasms--drug therapy<br/>Randomized Controlled Trials as Topic<br/>Research Report--standards<br/>Tegafur--administration & dosage<br/>Treatment Outcome<br/>Gemcitabine